PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-May-2023 SunMed Completes Acquisition of Respiratory & Anesthesia Consumables Business of Vyaire Medical Businesswire
01-May-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of adidas AG (ADDYY, ADDDF) on Behalf of Investors Businesswire
01-May-2023 Hanger Announces Pete Stoy as CEO Businesswire
01-May-2023 Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity Businesswire
01-May-2023 Tivic Announces Appointment of New Interim CFO, Kimberly Bambach, and Strategic Advisor to the Board, Christine Valauri Businesswire
01-May-2023 ImmunoTek Plasma Opens New Location in Baton Rouge Businesswire
01-May-2023 AleraCare Rebrands Nationally and Consolidates Ambulatory Infusion, Specialty Pharmacy, Home Infusion and Compounding Pharmacy Service Lines Businesswire
01-May-2023 Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference Businesswire
01-May-2023 Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) Businesswire
01-May-2023 Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited Businesswire
01-May-2023 Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer Businesswire
01-May-2023 Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID Businesswire
01-May-2023 bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer Businesswire
01-May-2023 OmniAb to Report First Quarter 2023 Financial Results on May 11 Businesswire
01-May-2023 COEUS Holdings Announces Rebranding to Reflect the Unification of Each Business Unit Into One Entity Businesswire
01-May-2023 U.S. FDA Accepts for Priority Review Supplemental Biologics License Application and EMA Validates Application for Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Businesswire
01-May-2023 Great Point Partners Expands Transatlantic Value Creation Through London Office Opening Businesswire
01-May-2023 Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting Businesswire
01-May-2023 Silence Therapeutics Completes Enrollment in Phase 2 Study of Zerlasiran (SLN360) in Subjects with Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events Businesswire
01-May-2023 Bristol Myers Squibb’s TRANSCEND FL and TRANSCEND NHL 001 Studies of Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma Meet Primary Endpoint of Overall Response Rate Businesswire